We advised our client with respect to the applicable sanitary regulations for the commercialization of protection-safety glasses. The assessment included the analysis of the different scenarios that could emerge due to the liability of the company in the commercialization of the mentioned products and regarding its use in different economic activities of the country. That implied that a broad regulatory analysis to solve the consultation and the liability limitations.
We advised our client regarding the renewal proceeding of the Certificate of Good Storage Practices and the strategy to be followed while renewal process is in progress, since the authority executed attachment measures of temporary closure of its storage facilities. In this sense, the case was complex as there were certain irregularities in the inspection proceeding conducted by the sanitary authority. Our team designed a sophisticated strategy to advert the authority of such inconsistencies.
We are currently providing assistance to Pharmaris in the execution of a contract of a Public Tender with the Peruvian government. Pharmaris was requested to perform a mass delivery of the product prior to the delivery date established in the contract as a consequence of the urgent need expressed by the entity. Notwithstanding, the corresponding conformity certification of the product was at that moment being matter of analysis by the authorized laboratory. After some short period of time, the laboratory finally expressed the non-conformity of the product. Our assessment implied a complex regulatory analysis, and the team provided legal advice with respect to the recall of the products and the mitigation actions related to the possible sanctions that could be imposed by the sanitary authority.
We provided assistance to Draeger Peru regarding and administrative sanctioning proceeding for spare parts of medical devices. In this case, the competent regulatory authority (DIGEMID) took an arbitrary position, and our defence consisted of demonstrating the legality of obtaining the sanitary registration and the compliance with the applicable regulations. The case has been complex since it involved the deep understating of the functioning of the medical devices that were questioned, and the special regulation applicable to such devices. For this effect, we had to work directly with the technicians’ experts of the client, to describe the exact composition of the parts objected by the authority, its functions on the equipment, determine if they could be considered as perishables parts or not, or if they are just replacements of the equipment. With that analysis we were able to structure the position and defence of our client. This was a case without much prior pronunciations of the authority, and in that sense imply not only a defence argument position, but also an explanation of the equipment, parts, and functionality, from a legal perspective supporting our position
We have also represented our client in the hearing held to defend our position, with favourable results.
The case is pending to be resolved.
We advise Laboratorio Durandin S.A.I. in their trademark portfolio.
Laboratorio Durandin S.A.I. is a Santiago based company. It is engaged in the health care industries, providing pharmaceutical products and/or other assistance services.
We advise Taiwan Liposome Co. Ltd. in their trademark portfolio.
Taiwan Liposome Co. Ltd operated as a biopharmaceutical company. The company provides drug delivery technology development, new drugs, researches and other services. Taiwan Liposome also produces lipid based formulations, parenteral drugs and other products.
We advise Farmamedica S.A. in their trademark portfolio.
FARMAMEDICA, S.A. is a Guatemalan pharmaceutical company with more than 50 years in the multivitamin market, which began operations in 1960. Its founder, with the knowledge and support of German science and technology, developed appropriate and specific formulas for the needs of Latin Americans, later giving way to the formulation of products that contribute to human health, specifically helping to strengthen the brain and nerves.
We advise Laboratorios Cofarma S.A. in their trademark portfolio.
LABORATORIOS COFARMA S.A. was founded in 1944 in Barranquilla (Colombia) and focused its activity on the development, manufacturing and marketing of products for home care and cleaning, being the pioneers, on a national scale, in the manufacture of aerosol products under the Bonaire brand.
It has a presence in the various marketing channels and reaches the different formats of its clients, through the categories in which it participates: Air (Bonaire), Cleaners (Pinolina, Tergo, Cyclon, Alaska, Casa Real), Insecticides (Rayol) and Fabrics (Bonaire, Alaska), with high-performance products that satisfy the needs of consumers.
We advise La Renon in their trademark portfolio.
La Renon is one of the top 40 Pharmaceutical companies of India and valued over half a billion USD in 2021. ‘La Renon’ was crafted with a commitment to bring ‘Transformation’ in the healthcare sector and in the lives of the patients.
The major segments that the company works with are Nephrology, Neurological Disorders, Critical Care, Gynaecology, Ortho, Gastroenterology, Urology, Respiratory and Cardio Metabolic.
Mega Lifesciences filed an opposition concerning its trademarks EUGICA and EUGICA HERBAL INFUSION—which refer to nutritional supplements and herbal remedies—, registered in class 5 (pharmaceutical products), against the client’s trademark EUGIA—related to an injectable drug. Neolpharma, in turn, filed an opposition based on its trademark ZEUGIAL —a medication for the treatment of neuropathic disease.
Eugia is a pharmaceutical company based in India, specializing in the provision of affordable and accessible specialized products, including General Injectables, Oncology, Ophthalmics, Hormonal products, and more. The company has a global presence, serving various regions around the world.
The Peruvian Trademark Office issued resolutions determining that both Mega Lifesciences’ and Neolpharma’s opposition are unfounded. Neolpharma Perú appealed and the procedure is pending.